Weekly CEO News from Richard Ingram
November 14, 2014

The stock market has reached nosebleed heights. I do not know if the wiseguys can keep it going through Thanksgiving.  But I hear that only 20% of fund managers are beating their benchmarks which is incredible given this bubble market

Read more

Written by Gary Markets closed mixed with the SP500 making a new closing high and the DOW in the red. The NASDAQ closed higher almost matching its February, 2000 closing high of 4696.69. By 4 pm the averages had stopped the

Read more

These agreements were created 100 years ago to give juvenile defendants and first-time offenders a chance to for rehabilitate themselves. Only in the last 20 years have DPAs migrated to the field of corporate criminals, treating them like kids who’ve

Read more

After a bumper 2013, the green energy space has seen modest trading so far this year due to valuation concerns. The industry trends, however, continue to improve and seem encouraging with the U.S. and China deciding to jointly act on

Read more

Almost all of our core market health indicators improved over the past week, however none of them could get back above the zero line. If the market can continue to climb it looks like our measures of risk and quality

Read more

With what little bounce activity gold and silver had experienced by Tuesday (CoT cut off date), the data show a jump in large speculators’ active bearishness and commercial entities longing and shorting gold. The Spec’s activity at least is productive.

Read more

Dear fellow Numpty: What is astonishing about the way banks cheated their clients by colluding to fix exchange rates to extract higher sums is not only that they did this to what they called “Numpty’s”, but when they did this.

Read more

Earlier today I posted my monthly update on Retail Sales. Those of us who routinely track this series know that the Advance Estimate will be followed by a second estimate next month and a third estimate the month after. How big

Read more

Shares of Geron Corporation (GERN) soared as much as 30% in today’s trading session after the company announced that it has established a partnership deal with a unit of Johnson & Johnson (JNJ) known as Jansen Biotech. The deal makes use

Read more

Groupon Downgraded Due to Growth Appreciation Period  — GAP Groupon (GRPN) was downgraded from Neutral to Dangerous this week after a rapid run up in its stock price. Rating changes can happen for any number of reasons. New Constructs’ stock

Read more